ArticleACS nano2026

Exploiting Macropinocytosis Drives Redox Vulnerability to Preferentially Target Drug-Resistant Cancer.

Jin Hong Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.